DNA vaccines (Southampton University)

DNA疫苗(南安普敦大学)

Report date: 2026/04/09 20:00:21

Base Information

Drug NameDNA vaccines (Southampton University)
Drug Alias NameLeukaemia DNA vaccine (Southampton University)p.DOM-WT1-37
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Promyelocytic, AcuteLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research TechnologyUniversity Of SouthamptonUniversity Hospital Southampton Nhs Foundation Trust +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncUniversity Hospital Southampton Nhs Foundation Trust
Active IndicationsN/A
Inactive IndicationsLeukemia, Promyelocytic, AcuteLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia